Every day counts: Accelerate access, beat cancer Virtual event

We live in an era of unprecedented innovation for people living with cancer. Yet, there is no value from innovation if patients for whom it is intended, cannot have access to it.

For cancer patients, Every Day Counts… but significant differences exist in patient access to innovative oncology therapies in Europe. Accelerating time to patient access will be critical to beat cancer in Europe.

The EFPIA Oncology Platform is delighted to invite you to participate in the ‘Every Day Counts’ Virtual Event on 21 September 2020, which will mark the launch of the “Every Day Counts: Improving time to patient access to innovative oncology therapies in Europe” report.

This publication presents the outcomes of the “Time to Patient Access” initiative, bringing together stakeholders from across Europe to establish a common understanding of the causes of delays and identify actionable solutions to improve patient access to new oncology treatments.

This engaging and interactive programme will feature a panel discussion and a digital tour across different European countries to discuss best practices and foster multi-stakeholder collaboration to accelerate time to patient access to innovative oncology therapies.


10.00 – 10.10 Welcome and Introductions

Nathalie Moll
, Director General, EFPIA and Natacha Bolaños, Global Alliances Manager and Regional Manager for Europe, Lymphoma Coalition

10.10 – 11.10 Panel Discussion: Improving Time to Patient Access to Innovative Oncology Medicines

Eugene van Rensburg, Head of Developed Markets, Commercial Operations, Astellas Pharma Europe

Tamara Milagre, Founder and President, EVITA - Hereditary Cancer

Anna Prokůpková, Advocacy and Project Manager, Association of European Cancer Leagues

Ly Tran, Deputy Secretary Scientific Advisory Council (Medicines Committee), National Health Care Institute (ZIN), the Netherlands

11.10 – 11.20 BREAK

11:20 – 12.20 Learnings from the ‘Time to Patient Access’ Report – How to Achieve Change

Ansgar Hebborn, Head of European Access Policy Affairs, Roche

Stefan Gijssels, CEO, Co-Founder and Member of the Board of Digestive Cancers Europe (DICE)

Bettina Ryll, Founder of the Melanoma Patient Network Europe, Member of the Horizon Europe Cancer Mission Board

Anne Willemsen, Senior Project Manager, EUnetHTA

12.20 – 12.25 Closing remarks